X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hypertension (147) 147
index medicus (129) 129
humans (113) 113
single-pill combination (107) 107
hypertension - drug therapy (90) 90
amlodipine (82) 82
male (72) 72
drug combinations (71) 71
female (71) 71
pharmacology & pharmacy (67) 67
middle aged (65) 65
blood-pressure (59) 59
antihypertensive agents - therapeutic use (53) 53
aged (51) 51
blood pressure (51) 51
blood pressure - drug effects (50) 50
valsartan (49) 49
drug therapy, combination (48) 48
antihypertensive agents - administration & dosage (44) 44
medicine, general & internal (41) 41
treatment outcome (40) 40
adult (39) 39
adherence (37) 37
fixed-dose combination (36) 36
therapy (36) 36
hydrochlorothiazide (34) 34
management (34) 34
peripheral vascular disease (34) 34
double-blind (33) 33
amlodipine - administration & dosage (32) 32
drug therapy (32) 32
antihypertensive agents - adverse effects (30) 30
hypertension - physiopathology (29) 29
medicine, research & experimental (29) 29
amlodipine - therapeutic use (27) 27
prevention (27) 27
single-pill combinations (27) 27
efficacy (25) 25
safety (25) 25
blood-pressure control (24) 24
dosage and administration (24) 24
fixed-dose combinations (24) 24
amlodipine - adverse effects (23) 23
cardiac & cardiovascular systems (23) 23
combination therapy (23) 23
internal medicine (23) 23
single-pill (23) 23
medication adherence (22) 22
risk factors (22) 22
metaanalysis (21) 21
arterial hypertension (20) 20
medicine & public health (20) 20
patient compliance (20) 20
double-blind method (19) 19
guidelines (19) 19
tolerability (19) 19
aliskiren (18) 18
antihypertensive drugs (18) 18
persistence (18) 18
atorvastatin (17) 17
cardiovascular risk (17) 17
diabetes (17) 17
diuretics (17) 17
cardiology (16) 16
clinical trials (16) 16
monotherapy (16) 16
single-pill amlodipine/atorvastatin (16) 16
telmisartan (16) 16
tetrazoles - administration & dosage (16) 16
young adult (16) 16
cardiovascular events (15) 15
hypertensive patients (15) 15
outcomes (15) 15
aged, 80 and over (14) 14
antihypertensive efficacy (14) 14
calcium channel blockers - therapeutic use (14) 14
cardiovascular-disease (14) 14
care and treatment (14) 14
retrospective studies (14) 14
review (14) 14
single pill combination (14) 14
tetrazoles - therapeutic use (14) 14
angiotensin ii type 1 receptor blockers - therapeutic use (13) 13
cardiovascular disease (13) 13
mortality (13) 13
pharmacology/toxicology (13) 13
resistant hypertension (13) 13
arterial-hypertension (12) 12
disease (12) 12
medicine (12) 12
original research (12) 12
valine - analogs & derivatives (12) 12
adolescent (11) 11
analysis (11) 11
calcium channel blockers - administration & dosage (11) 11
calcium-channel blocker (11) 11
cardiovascular diseases (11) 11
cardiovascular diseases - prevention & control (11) 11
cholesterol (11) 11
diseases of the circulatory system (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 03/2017, Volume 2017, Issue 3, p. CD009868
Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and disability worldwide, yet ASCVD risk factor control and secondary... 
Blood Pressure | Drugs | A.1 Drugs | Anticholesteremic Agents | Aspirin | Cardiovascular Diseases | Heart disease prevention | Costs | A.1.3 Other | Placebo Effect | A. Cardiovascular Disease: Primary Prevention | Insurance medicine | Cause of Death | Cholesterol | Randomized Controlled Trials as Topic | Prevention | Platelet Aggregation Inhibitors | Antihypertensive Agents | Heart & circulation | Medicine General & Introductory Medical Sciences | Drug Combinations | POLYPILL-BASED STRATEGY | Humans | Antihypertensive Agents [administration & dosage] | Anticholesteremic Agents [administration & dosage] | Cardiovascular Diseases [mortality; prevention & control] | RANDOMIZED CONTROLLED-TRIAL | PROACTIVE MULTIFACTORIAL INTERVENTION | Aspirin [administration & dosage] | USUAL CARE | MEDICINE, GENERAL & INTERNAL | Platelet Aggregation Inhibitors [administration & dosage] | HIGH-RISK | DOUBLE-BLIND | SINGLE-PILL COMBINATION | BLOOD-PRESSURE CONTROL | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Anticholesteremic Agents - adverse effects | Antihypertensive Agents - adverse effects | Aspirin - administration & dosage | Aspirin - adverse effects | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Platelet Aggregation Inhibitors - adverse effects
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 5/2012, Volume 52, Issue 5, pp. 645 - 655
Single-pill combinations (SPCs) of complementary antihypertensive agents provide patients with a simple and effective treatment regimen. To ensure that the... 
single‐pill combination | plasma renin activity | aliskiren | bioequivalence | hydrochlorothiazide | single-pill combination | EFFICACY | SAFETY | RENIN INHIBITOR ALISKIREN | PROGNOSTIC VALUE | TYPE-2 DIABETES | DOUBLE-BLIND TRIAL | TOLERABILITY | ARTERIAL-HYPERTENSION | ACUTE MYOCARDIAL-INFARCTION | BLOOD-PRESSURE CONTROL | PHARMACOLOGY & PHARMACY | Renin - metabolism | Hydrochlorothiazide - pharmacokinetics | Diuretics - pharmacokinetics | Tablets | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Fumarates - administration & dosage | Hypertension - drug therapy | Male | Hypertension - blood | Young Adult | Amides - adverse effects | Amides - pharmacokinetics | Adult | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Hydrochlorothiazide - adverse effects | Diuretics - administration & dosage | Double-Blind Method | Administration, Oral | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - pharmacokinetics | Fumarates - adverse effects | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Cross-Over Studies | Renin - antagonists & inhibitors | Analysis of Variance | Fumarates - pharmacokinetics | Models, Biological | Adolescent | Least-Squares Analysis | Amides - administration & dosage | Diuretics - adverse effects | Drug Combinations | Therapeutic Equivalency | Usage | Research | Hydrochlorothiazide | Pharmacokinetics | Diuretics
Journal Article
The Journal of Clinical Hypertension, ISSN 1524-6175, 06/2017, Volume 19, Issue 6, pp. 632 - 639
Journal Article